Displaying 51 - 96 of 96 results
Released Company Title Industry Topic
18 May 2022
12:22 CEST
GENTIAN DIAGNOSTICS ASA Minutes of annual general meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
09 May 2022
09:29 CEST
GENTIAN DIAGNOSTICS ASA The nomination committee's recommendation to the general meeting of Gentian Diagnostics ASA 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
28 Apr 2022
08:58 CEST
GENTIAN DIAGNOSTICS ASA Annual report 2021 20103010 Biotechnology Annual financial and audit Reports
28 Apr 2022
08:00 CEST
GENTIAN DIAGNOSTICS ASA First quarter 2022 financial report 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
27 Apr 2022
21:16 CEST
GENTIAN DIAGNOSTICS ASA NOTICE OF ANNUAL GENERAL MEETING 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
21 Apr 2022
08:27 CEST
GENTIAN DIAGNOSTICS ASA Invitation to presentation of first quarter 2022 results 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
20 Apr 2022
14:10 CEST
GENTIAN DIAGNOSTICS ASA Gentian Diagnostics signs distribution agreement with leading global diagnostics company for Cystatin C 20103010 Biotechnology Inside information
29 Mar 2022
09:37 CEST
GENTIAN DIAGNOSTICS ASA Release of the Gentian SARS-CoV-2 Total Antibody Immunoassay 20103010 Biotechnology Non-regulatory press releases
28 Feb 2022
12:19 CET
GENTIAN DIAGNOSTICS ASA Mandatory notification of trade 20103010 Biotechnology Mandatory notification of trade primary insiders
17 Feb 2022
08:00 CET
GENTIAN DIAGNOSTICS ASA Fourth quarter and full year 2021 report 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
11 Feb 2022
10:42 CET
GENTIAN DIAGNOSTICS ASA Invitation to presentation of 2021 fourth quarter results 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
31 Jan 2022
14:00 CET
GENTIAN DIAGNOSTICS ASA Global GCAL® distribution contract with Siemens Healthineers 20103010 Biotechnology Inside information
16 Dec 2021
13:33 CET
GENTIAN DIAGNOSTICS ASA Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
16 Dec 2021
08:47 CET
GENTIAN DIAGNOSTICS ASA Completed development of SARS Cov-2 antibody assay 20103010 Biotechnology Non-regulatory press releases
16 Dec 2021
08:34 CET
GENTIAN DIAGNOSTICS ASA Gentian Diagnostics presents at the DNB Nordic Healthcare Conference 20103010 Biotechnology Non-regulatory press releases
10 Dec 2021
09:42 CET
GENTIAN DIAGNOSTICS ASA Share capital increase registered - Correction* 20103010 Biotechnology Total number of voting rights and capital
09 Dec 2021
15:02 CET
GENTIAN DIAGNOSTICS ASA Share capital increase registered 20103010 Biotechnology Total number of voting rights and capital
30 Nov 2021
15:06 CET
GENTIAN DIAGNOSTICS ASA Mandatory notification of trade 20103010 Biotechnology Mandatory notification of trade primary insiders
29 Nov 2021
16:22 CET
GENTIAN DIAGNOSTICS ASA Share Issue in Connection with Employee Share Purchase Program 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
03 Nov 2021
12:31 CET
GENTIAN DIAGNOSTICS ASA Multicenter study confirms calprotectin’s role in risk stratification in COVID-19 20103010 Biotechnology Non-regulatory press releases
01 Nov 2021
13:07 CET
GENTIAN DIAGNOSTICS ASA New study supports the value of calprotectin in management of COVID-19 patients 20103010 Biotechnology Non-regulatory press releases
21 Oct 2021
08:00 CEST
GENTIAN DIAGNOSTICS ASA Third quarter 2021 financial report 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
11 Oct 2021
15:23 CEST
GENTIAN DIAGNOSTICS ASA Flaggemelding 20103010 Biotechnology Flagging
05 Oct 2021
18:00 CEST
GENTIAN DIAGNOSTICS ASA Product and market developments update 20103010 Biotechnology Inside information
05 Oct 2021
15:12 CEST
GENTIAN DIAGNOSTICS ASA Invitation to presentation of third quarter results 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
08 Sep 2021
15:48 CEST
GENTIAN DIAGNOSTICS ASA Norron Sicav Flagging i Gentian Diagnostics ASA 20103010 Biotechnology Flagging
26 Aug 2021
08:16 CEST
GENTIAN DIAGNOSTICS ASA Flaggemelding, Salix AS - Gentian Diagnostics ASA 20103010 Biotechnology Flagging
25 Aug 2021
18:38 CEST
GENTIAN DIAGNOSTICS ASA Mandatory notification of trade and disclosure of large shareholding 20103010 Biotechnology Mandatory notification of trade primary insiders
25 Aug 2021
08:00 CEST
GENTIAN DIAGNOSTICS ASA Second quarter 2021 report 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
19 Aug 2021
13:00 CEST
GENTIAN DIAGNOSTICS ASA Invitation to presentation of second quarter results 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
24 Jun 2021
11:48 CEST
GENTIAN DIAGNOSTICS ASA Gentian Diagnostics ASA – Approval and publication of prospectus, and transfer of listing from Euronext Growth (Oslo) to Oslo Børs 20103010 Biotechnology Prospectus / admission document
23 Jun 2021
11:48 CEST
GENTIAN DIAGNOSTICS ASA Transfer of shares to Oslo Børs approved, prepared for accelerated growth 20103010 Biotechnology Non-regulatory press releases
23 Jun 2021
10:53 CEST
GENTIAN DIAGNOSTICS ASA Oslo Børs - Vedtatt overføring av notering fra Euronext Growth til Oslo Børs – Gentian Diagnostics ASA 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
23 Jun 2021
10:53 CEST
GENTIAN DIAGNOSTICS ASA Oslo Børs – Resolution of transfer of listing from Euronext Growth to Oslo Børs – Gentian Diagnostics ASA 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
18 Jun 2021
07:30 CEST
GENTIAN DIAGNOSTICS ASA Gentian Diagnostics: Invitation to virtual presentation at 24 June 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
18 Jun 2021
07:15 CEST
GENTIAN DIAGNOSTICS ASA Gentian Diagnostics: A long-term revenue ambition of NOK 1 billion from a portfolio of high-impact diagnostic tests 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
07 May 2021
14:22 CEST
GENTIAN DIAGNOSTICS Application for transfer of shares admitted to trading on Euronext Growth to to Oslo Børs 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
07 May 2021
14:22 CEST
GENTIAN DIAGNOSTICS Søknad om overføring av aksjer tatt opp til handel fra Euronext Growth til Oslo Børs 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
07 May 2021
13:57 CEST
GENTIAN DIAGNOSTICS Gentian Diagnostics ASA – Application for admission to trading on Oslo Børs 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
07 May 2021
10:28 CEST
GENTIAN DIAGNOSTICS Gentian Diagnostics ASA – conversion to public limited liability company registered 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
04 May 2021
20:18 CEST
GENTIAN DIAGNOSTICS Minutes of Annual General Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
29 Apr 2021
22:14 CEST
GENTIAN DIAGNOSTICS 2021 Annual general meeting - proposal from the nomination committee 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
22 Apr 2021
08:33 CEST
GENTIAN DIAGNOSTICS Notice of Annual General Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
16 Apr 2021
12:37 CEST
GENTIAN DIAGNOSTICS Annual report 2020 20103010 Biotechnology Annual financial and audit Reports
16 Apr 2021
08:15 CEST
GENTIAN DIAGNOSTICS First quarter 2021 report 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
12 Apr 2021
13:55 CEST
GENTIAN DIAGNOSTICS Presentation of 2021 first quarter results for Gentian Diagnostics AS 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State